Stem Cell Therapy Concepts for Chronic Spinal Cord Injury

Courtesy: Dr Hidenori Suzuki, Dr Ashok Shyam, Ortho TV

 

Stem Cell Therapy and Regenerative Strategies for Chronic Spinal Cord Injury

Pathophysiology of Chronic Spinal Cord Injury

• Glial Scarring: Reactive astrocytes produce inhibitory extracellular matrix components, forming a dense glial scar that acts as a physical and biochemical barrier to axonal regeneration.
• Cystic Cavitation: Post-traumatic syrinx formation creates fluid-filled cavities exerting mechanical pressure and interrupting functional neural pathways.
• Loss of Supportive Architecture: Persistent cell death leads to chronic demyelination, blood-spinal cord barrier compromise, and localized ischemia.

Mechanisms of Stem Cell Action

• Cellular Replacement: Grafted cells differentiate into functional neurons, astrocytes, and oligodendrocytes to bridge disrupted tracts.
• Myelination and Neuroprotection: Oligodendrocyte differentiation promotes remyelination, prevents secondary neuronal apoptosis, and repairs the disrupted blood-spinal cord barrier.
• Immunomodulation: Donor cells modify the local microenvironment by attenuating chronic pro-inflammatory signaling.

Preclinical Findings: Induced Pluripotent Stem Cells and Chondroitinase ABC

• Glial Scar Modification: Pre-treatment with Chondroitinase ABC enzymatically degrades inhibitory chondroitin sulfate proteoglycans, facilitating host tissue permissiveness and local axonal sprouting.
• Cervical Contusion Model: In chronic cervical contusion models (cervical six to cervical seven levels evaluated eight weeks post-injury):
  • Pre-treatment significantly increases neural precursor cell graft survival in peri-lesional regions.
  • Transplanted cells differentiate predominantly into mature oligodendrocytes and neurons, establishing multi-layered myelin sheaths around host axons.
  • Transmission electron microscopy and patch-clamp electrophysiology confirm the formation of functional, host-to-graft synaptic connections.
  • Behavioral and electrophysiological assessments demonstrate improvements in forelimb grip strength and motor evoked potentials.

Clinical Trials and Translation

• Mesenchymal and Multipotent Stem Cells: Early phase clinical trials evaluating intravenous delivery in acute, subacute, and chronic spinal injury demonstrate safety and feasibility, with variable functional recovery.
• Functional Recovery Limits: While early motor gains—such as partial distal finger movement—can occur, clinical outcomes often fall short of meaningful quality-of-life improvements.
• Future Directions: Achieving robust functional restoration in chronic spinal cord injury will require optimized combination regimens pairing cell grafts with scar-modifying agents, targeted rehabilitation, and tailored biomaterial scaffolds.